Mesoblast Reports Fourth Quarter and Full-Year 2018 Financial Results and Operational Highlights MELBOURNE, Australia and NEW YORK, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB; Nasdaq: MESO) today reported strong financial results and provided operational highlights for the...

Mesoblast Provides Update on Transaction With Tasly Pharmaceutical Group NEW YORK and MELBOURNE, Australia, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB; Nasdaq: MESO) today announced that Tasly Pharmaceutical Group has received People's Republic of...

Mesoblast Financial Results Webcast for 2018 Financial Year NEW YORK and MELBOURNE, Australia, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO; ASX: MSB) will report financial results for the financial year and fourth quarter ended June 30,...